XB5007 Brain Cancer PDX Model

Model Information:

Anaplastic oligodendroglioma, WHO grade III, with positive glial markers and a moderate proliferative index on immunohistochemistry.

Request a Custom Quote for XB5007 Xenograft Model

Summary:

CategoryParameterModel Detail (XB5007)
IdentityModel IDXB5007
Cancer TypeBrain Cancer
Model TypePDX (Patient-Derived Xenograft)
Clinical BackgroundPatient Age51
Patient GenderMale
EthnicityN/A
DiagnosisAnaplastic Oligodendroglioma
StageWHO Grade 3 (Grade III)
Sample SiteBrain (Frontal/Temporal Lobe)
Genomics & BiomarkersPrimary DriverIDH1 Mutation & 1p/19q Co-deletion / TERT Promoter
CytogeneticsN/A
WES (Whole Exome)N/A
RNA-SeqN/A
CNV ProfileN/A
Mutational LoadN/A
CharacterizationSurface MarkersOlig2+, IDH1-R132H+, ATRX (Retained), Ki-67 (Moderate, ~15-20%)
Host StrainNSG (NOD scid gamma)
Inoculation RouteOrthotopic / Subcutaneous
Growth KineticN/A
PharmacologySoC ResponseN/A
Immune ProfilingN/A
Request a Custom Quote for XB5007 Xenograft Model

Growth Characteristics:

Request a Custom Quote for XB5007 Xenograft Model